France Opens Anteris Heart Valve Trial to Severe Aortic Stenosis Patients

Patients in France with severe aortic stenosis are eligible for a new trial. The study is being conducted by Anteris. It focuses on evaluating a heart valve intervention. Stock Titan reported the opening of enrollment. The trial aims to assess safety and efficacy of the device. Eligible participants will receive the investigational valve. The study could provide alternatives for high‑risk patients. Researchers will track outcomes to inform future approvals.